首页> 中文期刊> 《药学学报(英文版) 》 >In vivo retention of poloxamer-based in situ hydrogels for vaginal application in mouse and rat models

In vivo retention of poloxamer-based in situ hydrogels for vaginal application in mouse and rat models

         

摘要

The purpose of this study is to evaluate the in vivo retention capabilities of poloxamer-based in situ hydrogels for vaginal application with nonoxinol-9 as the model drug.Two in situ hydrogel formulations,which contained 18% poloxamer 407 plus 1% poloxamer 188 (GEL1,relative hydrophobic) or 6% poloxamer 188 (GEL2,relative hydrophilic),were compared with respect to the rheological properties,in vitro hydrogel erosion and drug release.The vaginal retention capabilities of these hydrogel formulations were further determined in two small animal models,including drug quantitation of vaginal rinsing fluid in mice and isotope tracing with 99mTc in rats.The two formulations exhibited similar phase transition temperatures ranging from 27 to 32 ℃.Increasing the content of poloxamer 188 resulted in higher rheological moduli under body temperature,but slightly accelerated hydrogel erosion and drug release.When compared in vivo,GEL1 was eliminated significantly slower in rat vagina than GEL2,while the vaginal retention of these two hydrogel formulations behaved similarly in mice.In conclusion,increases in the hydrophilic content of formulations led to faster hydrogel erosion,drug release and intravaginal elimination.Rats appear to be a better animal model than mice to evaluate the in situ hydrogel for vaginal application.

著录项

  • 来源
    《药学学报(英文版) 》 |2017年第4期|502-509|共8页
  • 作者单位

    Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai 201203, China;

    Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China;

    Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai 201203, China;

    Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China;

    Yunnan University of Traditional Chinese Medicine, Kunming 650500, China;

    Shanghai Institute of Planned Parenthood Research, National Population and Family Planning Key Laboratory of Contraceptives Drugs and Devices, Shanghai 200032, China;

    Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai 201203, China;

    Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China;

    Yunnan University of Traditional Chinese Medicine, Kunming 650500, China;

    Yunnan University of Traditional Chinese Medicine, Kunming 650500, China;

    Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai 201203, China;

    Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China;

    Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai 201203, China;

    Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号